Carl Zimmer is a columnist at The New York Times. He focuses on themes related to science, natural sciences, technology, and consumer tech, exploring the intersection of these fields in his writing. Carl's work has been featured in numerous publications including The Baltimore Sun, Yahoo News, and WIRED, among others.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Carl Zimmer's coverage is mainly focused on scientific and health topics, with a particular emphasis on citing data. He covers diverse subjects such as brain injuries, penguins, primates, ancient DNA, consciousness, sea creatures, the Omicron variant, Covid origins and vaccines among others. When reaching out to Carl Zimmer or pitching articles for his consideration ensure that they are backed by strong empirical evidence and include references to relevant research studies or datasets.
Given his significant focus on citing data in his coverage attributes it would be beneficial to provide him with access to new research findings or expert analysis based on robust scientific evidence. His broad range of covered themes also suggests he may be open to receiving pitches from experts across various scientific disciplines who can provide insightful commentary supported by credible data.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Carl Zimmer
The types of Ebola and hantavirus panicking officials are very different from the species identified decades ago, raising new questions about how to respond.
By: Carl Zimmer
This month, a pair of viruses seized the headlines. First came a hantavirus outbreak aboard a cruise ship, which caused as many as 13 infections, three of which were fatal.
By: Carl Zimmer
New York Times: The viruses causing the new outbreaks are much less familiar to science.
By: Carl Zimmer
The Bundibugyo virus, a little known type, previously had caused just two small outbreaks. Now it’s at the center of a rapidly widening epidemic in Africa.
As the Ebola outbreak spreads in Congo and Uganda, health workers are rushing to provide supportive care, hoping that some patients will recover on their own, while isolating the sick and tracing contacts of the infected.
By: Carl Zimmer
Health workers disinfect a coffin containing the body of a man presumed to have died of Ebola at a hospital in Mongbwalu, Democratic Republic of Congo, May 25, 2026.
By: Carl Zimmer
By As the Ebola outbreak spreads in Congo and Uganda, health workers are rushing to provide supportive care, hoping that some patients will
Researchers relied on a newer gene-editing technique that may make it possibl to engineer embryos, a prospect that has long alarmed bioethicists.
Researchers relied on a newer gene-editing technique that may make it possible to engineer embryos, a prospect that has long alarmed bioethicists.
The possibility of editing the DNA of human embryos became a matter of serious debate more than a decade ago, after the invention of CRISPR.
